Emily Caroline Walsh - Publications

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
clinical psychology

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Dalrymple KL, Wahrer KS, Walsh E, Rosenstein L, Zimmerman M. A Pilot Randomized Controlled Trial of the Feasibility and Acceptability of Acceptance and Commitment Therapy for Comorbid Social Anxiety Disorder in a Routine Practice Setting. Journal of Cognitive Psychotherapy. PMID 37369538 DOI: 10.1891/JCP-2022-0014  0.481
2023 Thompson KA, Miller AJ, Walsh EC, Bardone-Cone AM. Social media and disordered eating among middle-aged women: Not just an adolescent concern. Eating Behaviors. 50: 101748. PMID 37253297 DOI: 10.1016/j.eatbeh.2023.101748  0.534
2020 Bardone-Cone AM, Miller AJ, Thompson KA, Walsh EC. Predicting a comprehensive operationalization of eating disorder recovery: Examining self-concept, personality, and negative affect. The International Journal of Eating Disorders. PMID 32343432 DOI: 10.1002/Eat.23281  0.588
2020 Koller KA, Thompson KA, Miller AJ, Walsh EC, Bardone-Cone AM. Body appreciation and intuitive eating in eating disorder recovery. The International Journal of Eating Disorders. PMID 32020677 DOI: 10.1002/Eat.23238  0.594
2018 Rosenstein LK, Ellison WD, Walsh E, Chelminski I, Dalrymple K, Zimmerman M. The role of emotion regulation difficulties in the connection between childhood emotional abuse and borderline personality features. Personality Disorders. PMID 30091618 DOI: 10.1037/Per0000294  0.431
2018 Steinglass JE, Glasofer DR, Walsh E, Guzman G, Peterson CB, Walsh BT, Attia E, Wonderlich SA. Targeting habits in anorexia nervosa: a proof-of-concept randomized trial. Psychological Medicine. 1-8. PMID 29455696 DOI: 10.1017/S003329171800020X  0.57
2017 Walsh E, Rosenstein L, Dalrymple K, Chelminski I, Zimmerman M. The Importance of Assessing for Childhood Abuse and Lifetime PTSD in Bariatric Surgery Candidates. Journal of Clinical Psychology in Medical Settings. PMID 29159539 DOI: 10.1007/S10880-017-9518-7  0.488
2017 Zimmerman M, Walsh E, Friedman M, Boerescu DA, Attiullah N. Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice? Journal of Affective Disorders. 225: 449-452. PMID 28858659 DOI: 10.1016/J.Jad.2017.08.024  0.491
2017 Zimmerman M, Walsh E, Friedman M, Boerescu DA, Attiullah N. Identifying Remission From Depression on 3 Self-Report Scales. The Journal of Clinical Psychiatry. 78: 177-183. PMID 28234434 DOI: 10.4088/Jcp.16M10641  0.498
2017 Zimmerman M, Walsh E, Chelminski I, Dalrymple K. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials? Journal of Affective Disorders. 211: 60-64. PMID 28088058 DOI: 10.1016/J.Jad.2017.01.008  0.558
2017 Dalrymple KL, Walsh E, Rosenstein L, Chelminski I, Zimmerman M. Modification of the medical exclusion criterion in DSM-5 social anxiety disorder: Comorbid obesity as an example. Journal of Affective Disorders. 210: 230-236. PMID 28064111 DOI: 10.1016/J.Jad.2016.12.055  0.491
2016 Yusufov M, Dalrymple K, Bernstein MH, Walsh E, Rosenstein L, Chelminski I, Zimmerman M. Body mass index, depression, and suicidality: The role of self-esteem in bariatric surgery candidates. Journal of Affective Disorders. 208: 238-247. PMID 27792969 DOI: 10.1016/J.Jad.2016.10.005  0.481
2016 Zimmerman M, Multach MD, Clark HL, Walsh E, Rosenstein LK, Gazarian D. Inclusion/exclusion criteria in late life depression antidepressant efficacy trials. International Journal of Geriatric Psychiatry. PMID 27546477 DOI: 10.1002/Gps.4560  0.502
2016 Zimmerman M, Holst CG, Clark HL, Multach M, Walsh E, Rosenstein LK, Gazarian D. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years. Cns Drugs. PMID 27541608 DOI: 10.1007/S40263-016-0381-0  0.586
2016 Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Variability in the substance use disorder exclusion criterion in antidepressant efficacy trials. Journal of Affective Disorders. 198: 39-42. PMID 27002283 DOI: 10.1016/J.Jad.2016.03.024  0.56
2016 Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Symptom Severity and the Generalizability of Antidepressant Efficacy Trials: Changes During the Past 20 Years. Journal of Clinical Psychopharmacology. PMID 26848791 DOI: 10.1097/Jcp.0000000000000466  0.519
2016 Zimmerman M, Multach M, Walsh E, Rosenstein LK, Gazarian D, Clark HL. Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity. Cns Drugs. PMID 26818632 DOI: 10.1007/S40263-016-0314-Y  0.473
2015 Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling. Journal of Affective Disorders. 190: 357-361. PMID 26546771 DOI: 10.1016/J.Jad.2015.10.041  0.566
2015 Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Have Treatment Studies of Depression Become Even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published During the Past 20 Years. Mayo Clinic Proceedings. 90: 1180-6. PMID 26276679 DOI: 10.1016/j.mayocp.2015.06.016  0.456
2015 Hidalgo-Mazzei D, Walsh E, Rosenstein L, Zimmerman M. Comorbid bipolar disorder and borderline personality disorder and substance use disorder. The Journal of Nervous and Mental Disease. 203: 54-7. PMID 25494335 DOI: 10.1097/Nmd.0000000000000235  0.546
2014 Zimmerman M, Morgan TA, Young D, Chelminski I, Dalrymple K, Walsh E. Does Borderline Personality Disorder Manifest Itself Differently in Patients With Bipolar Disorder and Major Depressive Disorder? Journal of Personality Disorders. 1-7. PMID 25248008 DOI: 10.1521/Pedi_2014_28_169  0.587
2014 Zimmerman M, Chelminski I, Young D, Dalrymple K, Walsh E, Rosenstein L. A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder. The Journal of Clinical Psychiatry. 75: 601-7. PMID 24813209 DOI: 10.4088/Jcp.13M08961  0.59
Show low-probability matches.